NL-OMON38928已完成不适用
Effects of the selective mineralocorticoid receptor antagonist eplerenone on extracellular adenosine formation in humans in vivo - eplerenone and adenosine
niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 14 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 14
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy, male, age 18-40 years, written informed consent
- •(see also chapter 4.2 (Inclusion criteria) of the protocol)
排除标准
- •smoking, history of cardiovascular disease, hypertension, renal dysfunction, serum potassium > 4.7 mmol/L
- •(see also chapter 4.3 (Exclusion criteria) of the protocol)
研究者
相似试验
进行中（未招募）
不适用
Effects of eplerenone on forearm blood flowhealthy volunteersEUCTR2013-000189-12-NLniversity Medical Centre Nijmegen
已完成
2 期
Effects of mineralocorticoid receptor agonist on intradialytic hypotension: an open-label, randomized crossover studyIntradialytic hypotensionMineralocorticoid receptor agonistTCTR20200128004ampang hospital10
尚未招募
2 期
Effects of Mineralocorticoid Receptor Blockade on Metabolism - A Clinical TrialMetabolic and Endocrine - Metabolic disordersDiet and Nutrition - ObesityObesityACTRN12618001958279Dr Moe Thuzar32
进行中（未招募）
1 期
Effects of mineralocorticoid receptor stimulation on cognitive bias and social cognition in patients with major depression and healthy controls: what’s the role of NMDA receptors?depressed patients and healthy control subjectsEUCTR2014-005239-15-DECharité - Universitätsmedizin Berlin232
已完成
不适用
The effect of a mineralocorticoid receptor antagonist eplerenone on morning home BP in drug-resistant hypertensiodrug-resistant morning hypertensionJPRN-UMIN000014186Jichi Medical University School of Medicine100